Lv45
520 积分 2025-08-06 加入
Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review
22小时前
已完结
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
8天前
已完结
The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study
8天前
已完结
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study
11天前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
12天前
已完结
Predicting Induction Toxicity with 7+3: Analysis of SWOG Trial S1203
19天前
已关闭
Acute lymphocytic leukaemia
19天前
已完结
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial
20天前
已完结
Neo‐enhancers in T‐cell acute lymphoblastic Leukaemia (T‐ALL) and beyond
23天前
已完结
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
23天前
已完结
皖公网安备34019202002308
